Our Research

Discover our recent findings, catch up with news, and review in-depth resources.

Foreign Particulate Matter in Inhalation Products

Blog

Foreign Particulate Matter in Inhalation Products

Ensure inhalation product safety and compliance with Resolian’s advanced foreign particulate matter characterization and root cause analysis solutions.
Read more
Empowering Early-Career Scientists: Jennifer Hawkins’ Journey at the REID Bioanalytical Forum

News | Blog

Empowering Early-Career Scientists: Jennifer Hawkins’ Journey at the REID Bioanalytical Forum

Discover how Resolian supports early-career scientists like Jennifer Hawkins through opportunities at the REID Bioanalytical Forum. Learn about LC-MS/MS assay development and career growth in bioanalysis.
Read more
Preventing False Positives in BPO Benzene Analysis | Resolian

Case Studies | Videos

Preventing False Positives in BPO Benzene Analysis

Benzoyl peroxide can degrade to benzene during testing, creating false positives. Resolian’s antioxidant scavenger strategy prevents analytical artifacts.
Read more
Green Chemistry for Extractables & Leachables Testing | Resolian

Case Studies | Videos

Green Chemistry for Extractables & Leachables Testing

Discover how Resolian’s green chemistry LC-HRMS method for extractables & leachables testing cut runtime by 37% and solvent use – without compromising sensitivity or quality.
Read more

Blog | Posters

Developing CES Reaction Phenotyping Assay

Our work, presented at APA 2025, focuses on developing an in vitro CES reaction phenotyping using p-nitrophenyl acetate (p-NPA) as a universal substrate. In this study, we compared different CES substrates, optimized the experimental conditions and developed an LC-MS method for simultaneous detection of p-NPA and its metabolites.
Read more
Ultra-Trace NMBA Detection Using HILIC-MS | Resolian

Case Studies | Videos

Ultra-Trace NMBA Detection Using HILIC-MS

Learn how Resolian achieved 0.8 ng/mL NMBA detection using HILIC-MS – overcoming reverse-phase limitations for ultra-trace nitrosamine analysis in drug products.
Read more
Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.